$ABUS News Article - Antios Therapeutics and Arbut
Post# of 74
(Total Views: 188)
Posted On: 12/14/2021 8:25:50 AM
$ABUS News Article - Antios Therapeutics and Arbutus Biopharma Announce First Patient Dosed in Phase 2a Combination Trial of ATI-2173, AB-729 and Tenofovir Disoproxil Fumarate in Patients with Chronic Hepatitis B Virus Infection https://marketwirenews.com/news-releases/anti...53894.html
(0)
(0)Arbutus Biopharma Corporation (ABUS) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼